159 related articles for article (PubMed ID: 38299777)
1. Incidence of possible serious bacterial infection in young infants in the three high-burden countries of the Democratic Republic of the Congo, Kenya, and Nigeria: A secondary analysis of a large, multi-country, multi-centre clinical trial.
Lokangaka A; Ramani M; Bauserman M; Patterson J; Engmann C; Tshefu A; Cousens S; Qazi SA; Ayede AI; Adejuyigbe EA; Esamai F; Wammanda RD; Nisar YB; Coppieters Y
J Glob Health; 2024 Feb; 14():04009. PubMed ID: 38299777
[TBL] [Abstract][Full Text] [Related]
2. Simplified antibiotic regimens for young infants with possible serious bacterial infection when the referral is not feasible in the Democratic Republic of the Congo.
Lokangaka A; Ishoso D; Tshefu A; Kalonji M; Takoy P; Kokolomami J; Otomba J; Aboubaker S; Qazi SA; Nisar YB; Bahl R; Bose C; Coppieters Y
PLoS One; 2022; 17(6):e0268277. PubMed ID: 35771738
[TBL] [Abstract][Full Text] [Related]
3. Oral amoxicillin plus gentamicin regimens may be superior to the procaine-penicillin plus gentamicin regimens for treatment of young infants with possible serious bacterial infection when referral is not feasible: Pooled analysis from three trials in Africa and Asia.
Longombe AL; Ayede AI; Marete I; Mir F; Ejembi CL; Shahidullah M; Adejuyigbe EA; Wammanda RD; Tshefu A; Esamai F; Zaidi AK; Baqui AH; Cousens S
J Glob Health; 2022 Nov; 12():04084. PubMed ID: 36403158
[TBL] [Abstract][Full Text] [Related]
4. Management of possible serious bacterial infection in young infants where referral is not possible in the context of existing health system structure in Ibadan, South-west Nigeria.
Ayede AI; Ashubu OO; Fowobaje KR; Aboubaker S; Nisar YB; Qazi SA; Bahl R; Falade AG
PLoS One; 2021; 16(3):e0248720. PubMed ID: 33784321
[TBL] [Abstract][Full Text] [Related]
5. A multi-country implementation research initiative to jump-start scale-up of outpatient management of possible serious bacterial infections (PSBI) when a referral is not feasible: Summary findings and implications for programs.
Nisar YB; Aboubaker S; Arifeen SE; Ariff S; Arora N; Awasthi S; Ayede AI; Baqui AH; Bavdekar A; Berhane M; Chandola TR; Leul A; Sadruddin S; Tshefu A; Wammanda R; Nigussie A; Pyne-Mercier L; Pearson L; Brandes N; Wall S; Qazi SA; Bahl R
PLoS One; 2022; 17(6):e0269524. PubMed ID: 35696401
[TBL] [Abstract][Full Text] [Related]
6. Trends in the incidence of possible severe bacterial infection and case fatality rates in rural communities in Sub-Saharan Africa, South Asia and Latin America, 2010-2013: a multicenter prospective cohort study.
Hibberd PL; Hansen NI; Wang ME; Goudar SS; Pasha O; Esamai F; Chomba E; Garces A; Althabe F; Derman RJ; Goldenberg RL; Liechty EA; Carlo WA; Hambidge KM; Krebs NF; Buekens P; McClure EM; Koso-Thomas M; Patel AB
Reprod Health; 2016 May; 13(1):65. PubMed ID: 27221099
[TBL] [Abstract][Full Text] [Related]
7. Costs and cost-effectiveness of management of possible serious bacterial infections in young infants in outpatient settings when referral to a hospital was not possible: Results from randomized trials in Africa.
Garg CC; Tshefu A; Longombe AL; Kila JN; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Hyellashelni JD; Yoshida S; Gram L; Nisar YB; Qazi SA; Bahl R
PLoS One; 2021; 16(3):e0247977. PubMed ID: 33720960
[TBL] [Abstract][Full Text] [Related]
8. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial.
; Tshefu A; Lokangaka A; Ngaima S; Engmann C; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Ejembi CL; Ogala WN; Gram L; Cousens S
Lancet; 2015 May; 385(9979):1767-1776. PubMed ID: 25842221
[TBL] [Abstract][Full Text] [Related]
9. Clinical signs of possible serious infection and associated mortality among young infants presenting at first-level health facilities.
Nisar YB; Tshefu A; Longombe AL; Esamai F; Marete I; Ayede AI; Adejuyigbe EA; Wammanda RD; Qazi SA; Bahl R
PLoS One; 2021; 16(6):e0253110. PubMed ID: 34191832
[TBL] [Abstract][Full Text] [Related]
10. Implementation research on management of sick young infants with possible serious bacterial infection when referral is not possible in Jimma Zone, Ethiopia: Challenges and solutions.
Berhane M; Girma T; Tesfaye W; Jibat N; Abera M; Abrahim S; Aboubaker S; Nisar YB; Ahmad Qazi S; Bahl R; Abdissa A
PLoS One; 2021; 16(8):e0255210. PubMed ID: 34370744
[TBL] [Abstract][Full Text] [Related]
11. How long should young infants less than two months of age with moderate-mortality-risk signs of possible serious bacterial infection be hospitalised for? Study protocol for a randomised controlled trial from low- and middle-income countries.
PSBI Study Group
J Glob Health; 2023 Jul; 13():04056. PubMed ID: 37448340
[TBL] [Abstract][Full Text] [Related]
12. Implementation of the WHO guideline on treatment of young infants with signs of possible serious bacterial infection when hospital referral is not feasible in rural Zaria, Nigeria: Challenges and solutions.
Wammanda RD; Adamu SA; Joshua HD; Nisar YB; Qazi SA; Aboubaker S; Bahl R
PLoS One; 2020; 15(3):e0228718. PubMed ID: 32155155
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of implementation of simplified management of young infants with possible serious bacterial infection when referral is not feasible in tribal areas of Pune district, Maharashtra, India.
Roy S; Patil R; Apte A; Thibe K; Dhongade A; Pawar B; Nisar YB; Aboubaker S; Qazi SA; Bahl R; Patil A; Juvekar S; Bavdekar A
PLoS One; 2020; 15(8):e0236355. PubMed ID: 32833993
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Severe bacterial neonatal infections in Madagascar, Senegal, and Cambodia: A multicentric community-based cohort study.
Huynh BT; Kermorvant-Duchemin E; Chheang R; Randrianirina F; Seck A; Hariniaina Ratsima E; Andrianirina ZZ; Diouf JB; Abdou AY; Goyet S; Ngo V; Lach S; Pring L; Sok T; Padget M; Sarr FD; Borand L; Garin B; Collard JM; Herindrainy P; de Lauzanne A; Vray M; Delarocque-Astagneau E; Guillemot D;
PLoS Med; 2021 Sep; 18(9):e1003681. PubMed ID: 34582450
[TBL] [Abstract][Full Text] [Related]
16. Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the referral is not feasible in Palwal district of Haryana, India.
Mukhopadhyay R; Arora NK; Sharma PK; Dalpath S; Limbu P; Kataria G; Singh RK; Poluru R; Malik Y; Khera A; Prabhakar PK; Kumar S; Gupta R; Chellani H; Aggarwal KC; Gupta R; Arya S; Aboubaker S; Bahl R; Nisar YB; Qazi SA
PLoS One; 2021; 16(7):e0252700. PubMed ID: 34234352
[TBL] [Abstract][Full Text] [Related]
17. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial.
; Tshefu A; Lokangaka A; Ngaima S; Engmann C; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Ejembi CL; Ogala WN; Gram L; Cousens S
Lancet; 2015 May; 385(9979):1758-1766. PubMed ID: 25842223
[TBL] [Abstract][Full Text] [Related]
18. Optimal place of treatment for young infants aged less than two months with any low-mortality-risk sign of possible serious bacterial infection: Study Protocol for a randomised controlled trial from low- and middle-income countries.
PSBI Study Group
J Glob Health; 2023 Jul; 13():04055. PubMed ID: 37449353
[TBL] [Abstract][Full Text] [Related]
19. Community-based antibiotic delivery for possible serious bacterial infections in neonates in low- and middle-income countries.
Duby J; Lassi ZS; Bhutta ZA
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD007646. PubMed ID: 30970390
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age.
Puri D; Nisar YB; Tshefu A; Longombe AL; Esamai F; Marete I; Ayede AI; Adejuyigbe EA; Wammanda RD; Qazi SA; Bahl R
PLoS One; 2021; 16(2):e0247457. PubMed ID: 33626090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
